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Abstract. 4′,5,7-Trihydroxy-3′-prenylflavanone was synthesized and tested for antibacterial effects 
against Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. The 
synthesized compounds were characterized using UV, IR, MS and 1H and 13C NMR data. The antibacterial 
screening of the synthesized compounds were performed in vitro by the filter paper disc diffusion 
method. 
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1. Introduction 
Flavonoids are a group of common and naturally oc-
curring polyphenolic compounds that are widely 
found in the plant kingdom.
1
 They occur naturally as 
plant pigments in a broad range of fruits and vegeta-
bles as well as beverages such as tea, red wine, cof-
fee and beer.
2
 Flavonoids have been reported to 
exert multiple biological effects including antim-
icrobial,
3
 cytotoxicity,
4
 anti-inflammatory
5
 as well 
as anti-tumor activities.
6
 In this regard, several fla-
vonoids-bearing hydroxyl groups on the A or B ring 
have been reported to be potential antioxidant 
agents. It is now well established that such potency 
is mainly due to the ability of hydroxyl groups to 
donate hydrogen which enable the flavonoids to un-
dergo a redox reaction that helps them to scavenge 
free radicals.
7
 In addition, the presence of hydroxyl 
groups in the skeleton also contribute to high affinity 
for proteins and therefore acts as inhibitors of micro-
bial enzymes
8
 and inhibition of NADH dehydro-
genase of mitochondrial inner membranes.
9
 
 Prenylated flavanones are a unique class of natu-
rally occurring flavonoids characterized by the pres-
ence of a prenylated side chain in the flavonoid 
skeleton. It was reported that one phenolic group 
and certain degree of lipophilicity are required for 
the activity of the flavonoids.
10
 Substitution of the 
flavonoid ring system with prenyl groups would in-
crease their lipophilicity and consequently enhance 
their interaction with cellular membranes.
11
 4′,5,7-
Trihydroxy-3′-prenylflavanone (1) has been isolated 
for the first time in 1989 from the chloroform ex-
tract of the stem bark of Erythrina eriotriocha.
12
 
This paper now reports the short and facile synthesis 
of 4′,5,7-trihydroxy-3′-prenylflavanone (1) or 3′-
prenylnaringenin. 4′,5,7-Trihydroxy-3′-prenylflavanone 
(1) and it’s corresponding chalcone were screened in 
vitro for their antibacterial activity against four human 
pathogenic bacteria, Bacillus subtilis (G
+
), Es-
cherichia coli (G
–
), Staphylococcus aureus (G
+
) and 
Pseudomonas aeruginosa (G
–
). 
2. Experimental 
2.1 Materials, method and instruments 
Melting points were recorded on a Leica Galen III 
Kofler micro melting point apparatus and were un-
corrected. Infrared (IR) spectra were recorded on a 
Shimadzu 8000 or Perkin–Elmer series 1600 spec-
trometers as thin film (NaCl windows) for liquid 
samples or KBr pellet for solid samples. Mass spec-
tral data were obtained from Kent Mass Spectrometry 
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Service, UK. 
1
H and 
13
C NMR spectra (300 and 
75 MHz respectively) were recorded on a Bruker 
Avance 300 Spectrometer using CDCl3 and DMSO 
as solvent. Reactions were monitored by thin-layer 
chromatography (tlc) carried out on 0⋅2 mm Merck 
pre-coated silica gel plates (60 F254). 
2.2 4-Hydroxy-3-prenylbenzaldehyde (3) 
4-Hydroxybenzaldehyde (2) (1⋅1 g, 9⋅02 mmol) was 
dissolved in 10% aqueous KOH solution (12 mL) 
and 1-bromo-2-methyl-but-2-ene (2⋅5 g, 16⋅78 mmol) 
was added drop-wise within 30 min at room tempera-
ture. The reaction mixture was stirred at rt for 48 h 
and then acidified with HCl (10%) and extracted with 
EtOAc (3 × 25 mL). The organic layer was washed 
with water and brine, followed by drying over anhy-
drous MgSO4 and the solvent was evaporated under 
reduced pressure. The resulting syrup was chroma-
tographed on a silica gel column (PE
 
:
 
EtOAc, 4
 
:
 
1) 
to give 4-hydroxy-3-prenylbenzaldehyde (3) as col-
ourless crystals with m.p. 53–54°C (lit.
13
 57–60°C) 
in 12⋅8% yield. 
 Rf = 0⋅18 (PE
 
:
 
EtOAc, 9
 
:
 
1); IR νmax (KBr) cm
–1
: 
3215 (OH), 1658 (C=O), 1597 and 1446 (aromatic 
C=C), 1376 (C–O). 
 
1
H NMR (CDCl3) ppm: 1⋅75 (6H, s, H-4′ and H-
5′), 3⋅43 (2H, d, J = 7⋅5 Hz, H-1′), 5⋅35 (1H, m, H-2′), 
6⋅24 (1H, br, –OH), 6⋅94 (1H, d, J = 7⋅5 Hz, H-5), 
7⋅66–7⋅72 (2H, with unresolved couplings due to 
overlapping, H-2 and H-6) and 9⋅86 (1H, s, CHO). 
2.3 4-Methoxymethyloxy-3-prenylbenzaldehyde (4) 
To a solution of 4-hydroxy-3-prenylbenzaldehyde 
(3) (150 mg, 0⋅79 mmol) in CH2Cl2 (8 mL) at 0°C, 
N,N-diisopropylethylamine (5 mL) was added, this 
was followed by the addition of DMAP (40⋅0 mg, 
0⋅33 mmol) and the reaction mixture was stirred for 
15 min. MOMCl (70 mg, 0⋅89 mmol) was then added 
drop-wise at 0°C, and the mixture was stirred for 
15 min, after which time the temperature was in-
creased to room temperature with stirring overnight. 
The reaction mixture was then poured into water and 
extracted with CHCl3 (2 × 20 mL). The CHCl3 ex-
tracts were washed with water and brine, followed 
by drying over anhydrous MgSO4. The solvent was 
evaporated under reduced pressure, and the resulting 
syrup was chromatographed on a silica gel column 
(PE
 
:
 
EtOAc, 1
 
:
 
4) to give 4-methoxymethyloxy-3-
prenylbenzaldehye (4) (132 mg, 71⋅0%) as a color-
less liquid; Rf 0⋅46 (PE
 
:
 
EtOAc, 1 : 4). 
 IR νmax (neat) cm
–1
: 2823 and 2733 (C–H aldehyde), 
1686 (C=O), 1600 and 1451 (C=C aromatic), 1253 
(C–O). 
 NMR δH (CDCl3) ppm: 1⋅74 (3H, s, C-4′), 1⋅77 
(3H, s, C-5′), 3⋅39 (2H, d, J = 7⋅5 Hz, C-1′), 3⋅50 (3H, 
s, –OCH3), 5⋅27–5⋅35 (3H, m, –OCH2 and C-2′), 7⋅18 
(1H, d, J = 7⋅5 Hz, H-5), 7⋅69–7⋅72 (2H, m, H-2 and 
H-6), 9⋅89 (1H, s, –CHO). 
2.4 2′-Hydroxy-4,4′,6′-tris(methoxymethyloxy)-3-
prenylchalcone (6) 
A solution of 2-hydroxy-4,6-bis(methoxymethyloxy) 
acetophenone
14
 (5) (100 mg, 0⋅39 mmol) and 4-
methoxymethyloxy-3-prenylbenzaldehyde (4) (100 mg, 
0⋅43 mmol) in ethanol (10 mL), and 50% aq. solu-
tion of KOH (0⋅8 mL) was added. The mixture was 
then stirred at rt for 48 h. The mixture was poured into 
iced water, acidified with HCl (10%), and extracted 
with dichloromethane, and then washed with water 
and brine. The organic layer was dried over anhy-
drous MgSO4, and evaporated under reduced pres-
sure. The residual orange syrup was chromatographed 
on a silica gel column (PE
 
:
 
EtOAc, 9
 
:
 
1) to afford 
2′-hydroxy-4,4′,6′-tris(methoxymethyloxy)-3-prenyl-
chalcone (6) (139 mg, 76⋅1%) as a yellow crystalline 
with m.p. 43–45°C and Rf 0⋅31 (PE
 
:
 
EtOAc, 4
 
:
 
1). 
 IR νmax (KBr) cm
–1
: 3439 (OH), 1622 (C=O), 1590 
and 1415 (C=C aromatic), 1149 (C–O). 
 NMR δH (CDCl3) ppm: 1⋅75 (3H, s, H-5″), 1⋅78 
(3H, s, H-4″), 3⋅37 (2H, d, J = 7⋅2 Hz, H-1″), 3⋅51 
(9H, m, 3x –OCH3), 5⋅21–5⋅36 (7H, m, 3x –OCH2 and 
H-2″), 6⋅27 (1H, d, J = 2⋅4 Hz, H-3′), 6⋅33 (1H, d, 
J = 2⋅4 Hz, H-5′), 7⋅10 (1H, d, J = 9⋅0 Hz, H-5), 
7⋅43–7⋅45 (2H, m, with unresolved couplings due to 
overlapping, H-2 and H-6), 7⋅78 (1H, d, J = 15⋅6 Hz, 
H-α), 7⋅85 (1H, d, J = 15⋅6 Hz, H-β), 13⋅93 (1H, s,  
–OH). 
 NMR δC (CDCl3) ppm: 17⋅5 (C-5″, CH3), 25⋅5 (C-
4″, CH3), 28⋅5 (C-1″, –CH2), 55⋅5–56⋅5 (3x OCH3, 
CH3), 94⋅0 (–OCH2, CH2), 94⋅5 (C-1′, C-4°), 95⋅0 
(C-5′, C-H), 95⋅5 (–OCH2, CH2), 98⋅0 (C-3′, C–H), 
114⋅0 (C-5, C–H), 122⋅0 (C-2″, C–H), 125⋅5 (C-α, 
C–H), 127⋅5 (C-6, C–H), 129⋅5 (C-3, C-4°), 130⋅0 
(C-2, C–H), 131⋅5 (C-1, C-4°), 133⋅0 (C-3″, C-4°), 
143⋅0 (C-β, C–H), 157⋅0 (C-2′, C-4°), 160⋅0 (C-4, 
C-4°), 163⋅5 (C-6′, C-4°), 167⋅5 (C-4′, C-4°) and 
193⋅0 (C=O, C-4°). 
 MS: m/z 472 [M
+
, C26H32O8, (13)], 473 (8), 427 
(18), 395 (16), 367 (20), 263 (36), 259 (100), 241 
(64), 231 (27), 227 (22) and 197 (17). 
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2.5 4′,5,7-Trihydroxy-3′-prenylflavanone (1) 
A solution of 2′-hydroxy-4,4′,6′-tris(methoxymethy-
loxy)-3-prenylchalcone (6) (0⋅050 mg, 0⋅11 mmol) 
in MeOH (6 mL) was added 10% HCl (1 mL) and 
refluxed for 1 h. Then NaOAc was added and the re-
sulting mixture was refluxed for the next 3 h. The 
mixture was cooled and water (20 mL) was added and 
extracted with EtOAc (20 mL × 2), dried over anhy-
drous MgSO4, filtered, and evaporated to dryness to 
give 4′,5,7-trihydroxy-3′-prenylflavanone (1) (32⋅16 mg, 
89⋅33%) as a brown solid with m.p. 129–131°C 
(lit.
15
 134–135°C) and Rf 0⋅21 (PE
 
:
 
EtOAc, 1
 
:
 
5). 
 IR νmax (KBr) cm
–1
: 3406 (OH), 1664 (C=O), 1611 
and 1451 (C=C aromatic), 1166 (C–O). 
 UV λmax (EtOH) nm: 336 (shoulder), 289; NaOH; 
325, 248; AlCl3; 381, 306; AlCl3/HCl; 372, 307; 
NaOAc; 330, 286; NaOAc/H3BO3; 329 (sh), 286. 
 NMR δH (acetone) ppm: 1⋅70 (6H, s, H-4″ and H-
5″), 2⋅73 (1H, dd, J = 17⋅4 and 3⋅3 Hz, H-3a), 3⋅20 
(1H, dd, J = 17⋅4 and 12⋅9 Hz, H-3b), 3⋅36 (1H, d, 
J = 7⋅5 Hz, H-1″), 5⋅35 (1H, m, H-2″), 5⋅44 (1H, dd, 
J = 12⋅9 and 3⋅0 Hz, H-2), 5⋅97 (2H, s, H-6 and H-
8), 6⋅90 (1H, d, J = 8⋅1 Hz, H-5′), 7⋅23 (1H, dd, 
J = 8⋅1 and 2⋅1 Hz, H-6′), 7⋅29 (1H, d, J = 2⋅1 Hz, 
H-2′), 8⋅45 (1H, s, –OH), 9⋅61 (1H, s, –OH), 12⋅18 
(1H, s, –OH). 
 NMR δC (acetone) ppm: 17⋅0 (C-5″, CH3), 25⋅0 
(C-4″, CH3), 28⋅5 (C-1″, CH2), 42⋅5 (C-3, CH2), 79⋅0 
(C-2, CH), 95⋅0 (C-8, CH), 96⋅0 (C-6, CH), 102⋅5 
(C-4a, C-4°), 115⋅0 (C-5′, CH), 122⋅5 (C-2″, CH), 
125⋅0 (C-6′, CH), 128⋅0 (C-2′, CH), 128⋅2 (C-1′, C-
4°), 130⋅0 (C-3″, C-4°), 132⋅0 (C-3′, C-4°), 154⋅9 
(C-4′, C-4°), 155⋅5 (C-8a, C-4°), 164⋅5 (C-5, C-4°), 
166⋅5 (C-7, C-4°) and 196⋅0 (C=O, C-4°). 
 CIMS: m/z 340 [M
+
, C20H20O5, (65)], 341 (100), 
339 (32), 285 (13), 286 (15), 188 (20), 175 (87), 153 
(17), 141 (14) and 107 (10). 
2.6 Antibacterial screening 
The antibacterial activities of the synthesized com-
pounds (1) and (6) were studied against four bacte-
ria, viz. Bacillus subtilis (G
+
), Escherichia coli (G
–
), 
Staphylococcus aureus (G
+
) and Pseudomonas 
aeruginosa (G
–
). For the detection of antibacterial 
activities, the filter paper discs diffusion method 
was used.
16
 Streptomycin sulphate was used as posi-
tive control. Nutrient agar (NA) was used as basal 
medium for test bacteria. The discs were prepared 
by impregnating them in methanol solution of each 
sample (1 mg/1 mL). Each culture was prepared to a 
turbidity equivalent to McFarland and spread on the 
test tube. The paper disc containing the compound 
were placed on the agar surface previously inocu-
lated with suspension of each microbes to be tested. 
All determinations were made in duplicate. Inhibition 
diameter were determined after incubation at 37°C ± 1 
for 24 h. The antimicrobial activity was indicated by 
the presence of the clear inhibition zones around 
each disc. 
2.7 Minimum inhibition concentration 
The determination of the minimum inhibitory con-
centration (MIC), the serial dilution technique were 
followed using nutrient broth medium. The MIC was 
defined as the lowest concentration of samples that 
had restricted the growth of microbial.
17
 The MIC 
value of compound (1) were determined against Es-
cherichia coli (G
–
). 
3 Results and discussion 
3.1 Synthesis of 4′,5,7-trihydroxy-3′-
prenylflavanone (1) 
The synthesis of 4′,5,7-trihydroxy-3′-prenylflava-
none (1) was accomplished using the route shown in 
scheme 1. Lack of a general, efficient and regiose-
lective method for the introduction of a prenylated 
side chain was a major challenge for the synthesis of 
this particular compound. Nevertheless, the initial 
step which was the introduction of a prenyl group to 
4-hydroxybenzaldehyde (2) was carried out. The 
synthesis of 4-hydroxy-3-prenylbenzaldehyde (4) 
was achieved by treatment of 1-bromo-3-methylbut-
2-ene or prenyl bromide with 4-hydroxybenzaldehyde 
(2) in KOH 10% solution for 48 h at room tempera-
ture.
18
 The prenylation of (2) gave the desired product 
(3) in only 12⋅8% along with 4-O-prenylbenzalde-
hyde as a by-product. 
 The hydroxyl group of 4-hydroxy-3-prenylbenzal-
dehyde (3) was then protected as –OMOM derivative 
(4) using MOMCl, DMAP, NEt(i-Pr)2 in CH2Cl2 to 
furnish 4-methoxymethyloxy-3-prenylbenzaldehyde 
(4) as a colourless liquid in 71% yield. The Claisen 
condensation of compound (4) with 2-hydroxy-4,6-
bis(methoxymethyloxy)-acetophenone (5) yielded 
the corresponding chalcone (6) in 76⋅1% yield with m.p. 
43–45°C as yellow crystalline. The IR spectrum of
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Scheme 1. 
 
chalcone (6) showed an absorption frequency at 
1622 cm
–1
 indicating the presence of a conjugated 
carbonyl group and a broad peak at 3439 cm
–1
 due to 
the hydroxyl groups. The 
1
H NMR spectrum exhib-
ited the characteristic signals due to trans-olefinic 
protons at δ 7⋅78 (1H, d, J = 15⋅6 Hz, H-α) and 7⋅85 
(1H, d, J = 15⋅6 Hz, H-β) whereas the prenyl moiety 
resonated at δ 1⋅75 (3H, s, –CH3), 1⋅78 (3H, s, –CH3), 
3⋅37 (2H, d, J = 7⋅2 Hz, –CH2) and δ 5⋅21–5⋅36 (7H, 
m, 3x –OCH2 and H-allylic). The phenolic proton ap-
peared at δ 13⋅93. The aromatic protons of ring A ap-
peared at δ 6⋅27 (d, J = 2⋅4, H-3′) and 6⋅33 (d, J = 2⋅4, 
H-5′). The other aromatic protons of ring B appeared 
at δ 7⋅10 (d, J = 9⋅0, H-5) and both H-2 and H-6 ap-
peared at δ 7⋅43–7⋅45 (m) integrating for two protons. 
 The final step in the synthetic route to flavanone 
(1) was to cyclise the corresponding chalcone (6). 
Prior to this, chalcone (6) which was subjected to 
deprotection via acid hydrolysis (HCl 10%) and sub-
sequent treatment with excessive NaOAc in methanol 
has provided flavanone (1) as a brown solid with 
m.p. 129–131°C (lit.
15
 134–135°C). Interestingly, 
this reaction gave the desired flavanone (1) as a sin-
gle product in excellent yield (89⋅3%). 
 The presence of a broad peak at 3406 cm
–1
 due to 
the hydroxyl groups in the IR spectrum suggested 
that the protecting groups have been removed. The 
UV spectrum of flavanone (1) showed an intense 
band II at 289 nm with only a shoulder at 336 nm 
representing band I, which was typical for fla-
vanone.
19
 The 
1
H NMR data of flavanone (1) 
showed the signals of the prenyl group were still in-
tact at δ 1⋅70 (6H, s, 2x –CH3), 3⋅36 (1H, d, J = 7⋅5 Hz, 
–CH2) and 5⋅35 (1H, m, H-allylic). The formation of 
flavanone (1) was deduced from the characteristic 
signals at δ 2⋅73 (1H, dd, J = 17⋅4 and 3⋅3 Hz, H-
3a), 3⋅20 (1H, dd, J = 17⋅4 and 12⋅9 Hz, H-3b) and 
5⋅44 (1H, dd, J = 12⋅9 and 3⋅0 Hz, H-2). In addition, 
the signal of phenolic protons were observed at δ 8⋅45 
(1H, s, H-4′), 9⋅61 (1H, s, H-7) and 12⋅18 (1H, s, H-
5). The aromatic protons of ring B gave an AMX 
coupling system at δ 6⋅90 (1H, d, J = 8⋅1 Hz, H-5′), 
7⋅23 (1H, dd, J = 8⋅1 and 2⋅1 Hz, H-6′), 7⋅29 (1H, d, 
J = 2⋅1 Hz, H-2′) whereas the protons of ring A were 
seen at δ 5⋅44 (1H, dd, J = 12⋅9 and 3⋅0 Hz, H-2) 
and 5⋅97 (2H, s, H-6 and H-8). The spectral data of 
compound (1) (UV, IR, MS, 
1
H and 
13
C NMR) were 
similar to that obtained from natural sample.
12
 
3.2 Antibacterial screening 
The antibacterial activities of compounds (1) and (6) 
has been assayed at the concentration 1000 μg/mL 
against four human pathogenic bacteria. Among them, 
two were gram-positive and the other two were gram-
negative. The inhibitory effect of compounds (1) 
and (6) against these organisms are given in table 1. 
The screening results indicate that only compound 
(1) was active against a gram-negative bacteria, Es-
cherichia coli with a mean zone of inhibition 
12⋅5 ± 0⋅3 mm (table 1). 
3.3 Determination of the minimum inhibitory  
concentration (MIC) 
The active sample in the disc diffusion method was 
then tested for its activity by the serial dilution method
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Table 1. Antibacterial screening for the compounds (1) and (6). 
 Diameter of the zone of inhibition (mm) 
 
Organism Chalcone (6) Prenylflavanone (1) Streptomycin sulphate 
 
Bacillus subtilis – – 22⋅0 ± 0⋅3 
Staphylococcus aureus – – 22⋅5 ± 0⋅7 
Escherichia coli – 12⋅5 ± 0⋅3 22⋅0 ± 0⋅0 
Pseudomonas aeruginosa – – 22⋅0 ± 0⋅0 
Data represent mean ± SD of three independent experiments performed in duplicate 
 
 
to determine the minimum inhibition concentration 
(MIC-value). The MIC value obtained for 4′,5,7-
trihydroxy-3′-prenylflavanone (1) was 1000 μg/mL 
against Escherichia coli. 
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